Viewing Study NCT02313103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:33 PM
Ignite Modification Date: 2026-02-20 @ 4:43 PM
Study NCT ID: NCT02313103
Status: COMPLETED
Last Update Posted: 2017-10-26
First Post: 2014-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects
Sponsor: USWM, LLC (dba US WorldMeds)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renally Impaired Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ESRD View
None End Stage Renal Disease View
None Normal Healthy Volunteers View
None Renally Impaired View